-
1
-
-
44649187924
-
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials
-
18550004 10.1016/j.cgh.2008.03.014 1:CAS:528:DC%2BD1cXos1WjsLg%3D
-
Peyrin-Biroulet L, Deltenre P, de Suray N, et al. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol. 2008;6:644-653.
-
(2008)
Clin Gastroenterol Hepatol
, vol.6
, pp. 644-653
-
-
Peyrin-Biroulet, L.1
Deltenre, P.2
De Suray, N.3
-
2
-
-
28844473957
-
Infliximab for induction and maintenance therapy for ulcerative colitis
-
16339095 10.1056/NEJMoa050516 1:CAS:528:DC%2BD2MXhtlShurjE
-
Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462-2476.
-
(2005)
N Engl J Med
, vol.353
, pp. 2462-2476
-
-
Rutgeerts, P.1
Sandborn, W.J.2
Feagan, B.G.3
-
3
-
-
4644265354
-
Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease
-
15472531 10.1097/00054725-200409000-00025
-
Velayos FS, Sandborn WJ. Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease. Inflamm Bowel Dis. 2004;10:657-660.
-
(2004)
Inflamm Bowel Dis
, vol.10
, pp. 657-660
-
-
Velayos, F.S.1
Sandborn, W.J.2
-
4
-
-
41349088375
-
Risk factors for opportunistic infections in patients with inflammatory bowel disease
-
18294633 10.1053/j.gastro.2008.01.012
-
Toruner M, Loftus EV Jr, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134:929-936.
-
(2008)
Gastroenterology
, vol.134
, pp. 929-936
-
-
Toruner, M.1
Loftus Jr., E.V.2
Harmsen, W.S.3
-
5
-
-
1842479859
-
Diagnosis, management, and treatment of hepatitis C
-
15057920 10.1002/hep.20119
-
Strader DB, Wright T, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39:1147-1171.
-
(2004)
Hepatology
, vol.39
, pp. 1147-1171
-
-
Strader, D.B.1
Wright, T.2
Thomas, D.L.3
-
6
-
-
0031887203
-
Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection
-
9486392 10.1046/j.1365-2249.1998.00469.x 1:STN:280:DyaK1c7ksFOqtQ%3D%3D
-
Kallinowski B, Haseroth K, Marinos G, et al. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol. 1998;111:269-277.
-
(1998)
Clin Exp Immunol
, vol.111
, pp. 269-277
-
-
Kallinowski, B.1
Haseroth, K.2
Marinos, G.3
-
7
-
-
0029871106
-
IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C
-
8601375 10.1007/BF02093821 1:CAS:528:DyaK28XitV2hu7Y%3D
-
Kishihara Y, Hayashi J, Yoshimura E, et al. IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C. Dig Dis Sci. 1996;41:315-321.
-
(1996)
Dig Dis Sci
, vol.41
, pp. 315-321
-
-
Kishihara, Y.1
Hayashi, J.2
Yoshimura, E.3
-
8
-
-
0031427384
-
Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection
-
9440625 10.1023/A:1018804426724 1:STN:280:DyaK1c7gtFGktw%3D%3D
-
Nelson DR, Lim HL, Marousis CG, et al. Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci. 1997;42:2487-2494.
-
(1997)
Dig Dis Sci
, vol.42
, pp. 2487-2494
-
-
Nelson, D.R.1
Lim, H.L.2
Marousis, C.G.3
-
9
-
-
12644302184
-
Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C
-
9021719 1:STN:280:DyaK2s7ntlyhsg%3D%3D
-
Fukuda R, Ishimura N, Ishihara S, et al. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver. 1996;16:390-399.
-
(1996)
Liver
, vol.16
, pp. 390-399
-
-
Fukuda, R.1
Ishimura, N.2
Ishihara, S.3
-
10
-
-
0030052322
-
Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C
-
8591843 1:STN:280:DyaK287mt1SnsA%3D%3D
-
Larrea E, Garcia N, Qian C, et al. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology. 1996;23:210-217.
-
(1996)
Hepatology
, vol.23
, pp. 210-217
-
-
Larrea, E.1
Garcia, N.2
Qian, C.3
-
11
-
-
7044270670
-
Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: Hepatitis C, hepatitis B, and HIV infection
-
15479865 10.1136/ard.2004.028209 1:CAS:528:DC%2BD2cXhtVajtr3M
-
Calabrese LH, Zein N, Vassilopoulos D. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection. Ann Rheum Dis. 2004;63:ii18-ii24.
-
(2004)
Ann Rheum Dis
, vol.63
-
-
Calabrese, L.H.1
Zein, N.2
Vassilopoulos, D.3
-
12
-
-
13844294333
-
Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: A phase 2 randomized, double-blind, placebo-controlled study
-
15791697 10.1016/j.jhep.2004.11.025 1:CAS:528:DC%2BD2MXhtlensr0%3D
-
Zein NN. Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. J Hepatol. 2005;42:315-322.
-
(2005)
J Hepatol
, vol.42
, pp. 315-322
-
-
Zein, N.N.1
-
13
-
-
0019319257
-
A simple index of Crohn's-disease activity
-
6102236 10.1016/S0140-6736(80)92767-1 1:STN:280:DyaL3c7kt1Wjtg%3D%3D
-
Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1:514.
-
(1980)
Lancet
, vol.1
, pp. 514
-
-
Harvey, R.F.1
Bradshaw, J.M.2
-
14
-
-
0023521441
-
Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study
-
3317057 10.1056/NEJM198712243172603 1:STN:280:DyaL1c%2FmsFOkuw%3D%3D
-
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625-1629.
-
(1987)
N Engl J Med
, vol.317
, pp. 1625-1629
-
-
Schroeder, K.W.1
Tremaine, W.J.2
Ilstrup, D.M.3
-
15
-
-
59849104111
-
Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis
-
18623174 10.1002/ibd.20520
-
Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660-1666.
-
(2008)
Inflamm Bowel Dis
, vol.14
, pp. 1660-1666
-
-
Lewis, J.D.1
Chuai, S.2
Nessel, L.3
-
16
-
-
77949652854
-
Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity
-
20096379 10.1016/j.cgh.2010.01.001
-
Vermeire S, Schreiber S, Sandborn WJ, et al. Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity. Clin Gastroenterol Hepatol. 2010;8:357-363.
-
(2010)
Clin Gastroenterol Hepatol
, vol.8
, pp. 357-363
-
-
Vermeire, S.1
Schreiber, S.2
Sandborn, W.J.3
-
17
-
-
65449136656
-
Diagnosis, management, and treatment of hepatitis C: An update
-
19330875 10.1002/hep.22759 1:CAS:528:DC%2BD1MXkslWjs7o%3D
-
Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335-1374.
-
(2009)
Hepatology
, vol.49
, pp. 1335-1374
-
-
Ghany, M.G.1
Strader, D.B.2
Thomas, D.L.3
-
18
-
-
34249065208
-
Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease
-
17531027 10.1111/j.1572-0241.2007.01131.x
-
Abdelmalek MF, Liu C, Valentine JF. Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease. Am J Gastroenterol. 2007;102:1333-1334.
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 1333-1334
-
-
Abdelmalek, M.F.1
Liu, C.2
Valentine, J.F.3
-
19
-
-
0035135319
-
Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection
-
11246620 10.1097/00042737-200102000-00016 1:STN:280: DC%2BD3M3ksVOrtA%3D%3D
-
Campbell S, Ghosh S. Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection. Eur J Gastroenterol Hepatol. 2001;13:191-192.
-
(2001)
Eur J Gastroenterol Hepatol
, vol.13
, pp. 191-192
-
-
Campbell, S.1
Ghosh, S.2
-
20
-
-
0037280276
-
Treatment of patients with Crohn's disease and concomitant chronic hepatitis C with a chimeric monoclonal antibody to TNF
-
12591081 10.1111/j.1572-0241.2003.07245.x
-
Holtmann MH, Galle PR, Neurath MF. Treatment of patients with Crohn's disease and concomitant chronic hepatitis C with a chimeric monoclonal antibody to TNF. Am J Gastroenterol. 2003;98:504-505.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 504-505
-
-
Holtmann, M.H.1
Galle, P.R.2
Neurath, M.F.3
-
21
-
-
0036165844
-
Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection
-
11845808 10.1053/gast.2002.31602
-
Biancone L, Del Vecchio Blanco G, Pallone F, et al. Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection. Gastroenterology. 2002;122:593-594.
-
(2002)
Gastroenterology
, vol.122
, pp. 593-594
-
-
Biancone, L.1
Del Vecchio Blanco, G.2
Pallone, F.3
-
22
-
-
77957325399
-
Inflammatory bowel disease and hepatitis B and C in Western Balkans: A referral centre study and review of the literature
-
21122543 10.1016/j.crohns.2010.03.001
-
Katsanos KH, Tsianos VE, Zois CD, et al. Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature. J Crohns Colitis. 2010;4:450-465.
-
(2010)
J Crohns Colitis
, vol.4
, pp. 450-465
-
-
Katsanos, K.H.1
Tsianos, V.E.2
Zois, C.D.3
-
23
-
-
71449100743
-
Inflammatory bowel disease and hepatitis B and C
-
19896313 10.1016/j.gcb.2009.03.021
-
Chevaux JB, Bigard MA, Bensenane M, et al. Inflammatory bowel disease and hepatitis B and C. Gastroenterol Clin Biol. 2009;33:1082-1093.
-
(2009)
Gastroenterol Clin Biol
, vol.33
, pp. 1082-1093
-
-
Chevaux, J.B.1
Bigard, M.A.2
Bensenane, M.3
-
24
-
-
72049091520
-
The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease
-
19855102 10.1093/bmb/ldp036 1:CAS:528:DC%2BD1MXhsFOht7rN
-
Shale MJ. The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease. Br Med Bull. 2009;92:61-77.
-
(2009)
Br Med Bull
, vol.92
, pp. 61-77
-
-
Shale, M.J.1
-
25
-
-
71449093991
-
Review article: Chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease
-
19681818 10.1111/j.1365-2036.2009.04112.x 1:CAS:528: DC%2BC3cXnvFClsQ%3D%3D
-
Shale MJ, Seow CH, Coffin CS, et al. Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease. Aliment Pharmacol Ther. 2010;31:20-34.
-
(2010)
Aliment Pharmacol Ther
, vol.31
, pp. 20-34
-
-
Shale, M.J.1
Seow, C.H.2
Coffin, C.S.3
-
26
-
-
67349251600
-
Hepatitis C virus and inflammatory bowel disease
-
18975088 10.1007/s10620-008-0489-2
-
Horn TL, Reynolds J, de Villiers W, et al. Hepatitis C virus and inflammatory bowel disease. Dig Dis Sci. 2009;54:1171-1177.
-
(2009)
Dig Dis Sci
, vol.54
, pp. 1171-1177
-
-
Horn, T.L.1
Reynolds, J.2
De Villiers, W.3
-
27
-
-
0035158696
-
Hepatitis B and C virus infection in Crohn's disease
-
11720317 10.1097/00054725-200111000-00002 1:STN:280: DC%2BD3MnnsVeltw%3D%3D
-
Biancone L, Pavia M, Del Vecchio Blanco G, et al. Hepatitis B and C virus infection in Crohn's disease. Inflamm Bowel Dis. 2001;7:287-294.
-
(2001)
Inflamm Bowel Dis
, vol.7
, pp. 287-294
-
-
Biancone, L.1
Pavia, M.2
Del Vecchio Blanco, G.3
-
28
-
-
77957188851
-
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
-
20577000 10.1136/gut.2010.208413 1:STN:280:DC%2BC3cfivVOnug%3D%3D
-
Loras C, Gisbert JP, Minguez M, et al. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut. 2010;59:1340-1346.
-
(2010)
Gut
, vol.59
, pp. 1340-1346
-
-
Loras, C.1
Gisbert, J.P.2
Minguez, M.3
-
29
-
-
60749113827
-
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: A nationwide, multicenter study
-
19098850 10.1038/ajg.2008.4 1:CAS:528:DC%2BD1MXht1Sgsg%3D%3D
-
Loras C, Saro C, Gonzalez-Huix F, et al. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol. 2009;104:57-63.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 57-63
-
-
Loras, C.1
Saro, C.2
Gonzalez-Huix, F.3
-
30
-
-
77952679364
-
Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France
-
19885908 10.1002/ibd.21147
-
Chevaux JB, Nani A, Oussalah A, et al. Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France. Inflamm Bowel Dis. 2010;16:916-924.
-
(2010)
Inflamm Bowel Dis
, vol.16
, pp. 916-924
-
-
Chevaux, J.B.1
Nani, A.2
Oussalah, A.3
-
31
-
-
33745929069
-
Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: A case study and review of the literature
-
16369233
-
Alderson JW, Van Dinter TG Jr, Opatowsky MJ, et al. Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature. MedGenMed. 2005;7:7.
-
(2005)
MedGenMed
, vol.7
, pp. 7
-
-
Alderson, J.W.1
Van Dinter Jr., T.G.2
Opatowsky, M.J.3
-
32
-
-
54949145730
-
Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection
-
18688917 1:CAS:528:DC%2BD1cXhtlWit7nI
-
Ferri C, Ferraccioli G, Ferrari D, et al. Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection. J Rheumatol. 2008;35:1944-1949.
-
(2008)
J Rheumatol
, vol.35
, pp. 1944-1949
-
-
Ferri, C.1
Ferraccioli, G.2
Ferrari, D.3
-
33
-
-
33845585614
-
Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus
-
10.1093/rheumatology/kel191 1:CAS:528:DC%2BD28XhtlChtbbL
-
Marotte H, Fontanges E, Bailly F, et al. Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus. Rheumatology (Oxford). 2007;46:97-99.
-
(2007)
Rheumatology (Oxford)
, vol.46
, pp. 97-99
-
-
Marotte, H.1
Fontanges, E.2
Bailly, F.3
-
34
-
-
0142218784
-
Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection
-
14583571 10.1136/ard.62.11.1078 1:CAS:528:DC%2BD3sXpsVSks7c%3D
-
Peterson JR, Hsu FC, Simkin PA, et al. Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis. 2003;62:1078-1082.
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 1078-1082
-
-
Peterson, J.R.1
Hsu, F.C.2
Simkin, P.A.3
-
35
-
-
0033631713
-
Prevalence of hepatitis C in patients with chronic inflammatory bowel disease in the region of Nice and evaluation of risk factors
-
10679588 1:STN:280:DC%2BD3c7ksFyiuw%3D%3D
-
Longo F, Hebuterne X, Tran A, et al. Prevalence of hepatitis C in patients with chronic inflammatory bowel disease in the region of Nice and evaluation of risk factors. Gastroenterol Clin Biol. 2000;24:77-81.
-
(2000)
Gastroenterol Clin Biol
, vol.24
, pp. 77-81
-
-
Longo, F.1
Hebuterne, X.2
Tran, A.3
-
36
-
-
0030589563
-
Suppression of apoptotic cell death by hepatitis C virus core protein
-
8955036 10.1006/viro.1996.0644 1:CAS:528:DyaK28XnsF2ktbc%3D
-
Ray RB, Meyer K, Ray R. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology. 1996;226:176-182.
-
(1996)
Virology
, vol.226
, pp. 176-182
-
-
Ray, R.B.1
Meyer, K.2
Ray, R.3
-
37
-
-
0031892177
-
Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein
-
9442069 10.1074/jbc.273.4.2256 1:CAS:528:DyaK1cXnsVKrtg%3D%3D
-
Ray RB, Meyer K, Steele R, et al. Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein. J Biol Chem. 1998;273:2256-2259.
-
(1998)
J Biol Chem
, vol.273
, pp. 2256-2259
-
-
Ray, R.B.1
Meyer, K.2
Steele, R.3
-
38
-
-
33749627330
-
How to modulate inflammatory cytokines in liver diseases
-
17032402 10.1111/j.1478-3231.2006.01339.x 1:CAS:528:DC%2BD28Xht12mtbnN
-
Tilg H, Kaser A, Moschen AR. How to modulate inflammatory cytokines in liver diseases. Liver Int. 2006;26:1029-1039.
-
(2006)
Liver Int
, vol.26
, pp. 1029-1039
-
-
Tilg, H.1
Kaser, A.2
Moschen, A.R.3
-
39
-
-
0026691627
-
Serum levels of cytokines in chronic liver diseases
-
1612333 1:CAS:528:DyaK38XkvVOrt7s%3D
-
Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology. 1992;103:264-274.
-
(1992)
Gastroenterology
, vol.103
, pp. 264-274
-
-
Tilg, H.1
Wilmer, A.2
Vogel, W.3
-
40
-
-
0028153997
-
Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis
-
7509363 10.1084/jem.179.3.841 1:CAS:528:DyaK2cXhs1Wgtr4%3D
-
Gonzalez-Amaro R, Garcia-Monzon C, Garcia-Buey L, et al. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med. 1994;179:841-848.
-
(1994)
J Exp Med
, vol.179
, pp. 841-848
-
-
Gonzalez-Amaro, R.1
Garcia-Monzon, C.2
Garcia-Buey, L.3
-
41
-
-
0034754477
-
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
-
11677200 10.1053/gast.2001.28674 1:CAS:528:DC%2BD3MXpt1SrsLk%3D
-
Sandborn WJ, Hanauer SB, Katz S, et al. Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2001;121:1088-1094.
-
(2001)
Gastroenterology
, vol.121
, pp. 1088-1094
-
-
Sandborn, W.J.1
Hanauer, S.B.2
Katz, S.3
|